Kezar Life Sciences Q3 EPS $(0.32) Beats $(0.35) Estimate, Sales $7.00K
Kezar Life Sciences Q3 EPS $(0.32) Beats $(0.35) Estimate, Sales $7.00K
Kezar Life Sciences 第三季度每股收益（0.32 美元）高於預期（0.35 美元），銷售額爲700萬美元
Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.35) by 8.57 percent. This is a 28 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $7.00 thousand in sales this quarter.
Kezar Life Sciences（納斯達克股票代碼：KZR）公佈季度每股虧損0.32美元（0.32美元），比分析師普遍估計的0.35美元（0.35）高出8.57％。這比去年同期每股虧損0.25美元（0.25美元）下降了28％。該公司報告本季度銷售額爲7,000美元。